Literature DB >> 22764680

CRDOCK: an ultrafast multipurpose protein-ligand docking tool.

Álvaro Cortés Cabrera1, Javier Klett, Helena G Dos Santos, Almudena Perona, Rubén Gil-Redondo, Sandrea M Francis, Eva M Priego, Federico Gago, Antonio Morreale.   

Abstract

An ultrafast docking and virtual screening program, CRDOCK, is presented that contains (1) a search engine that can use a variety of sampling methods and an initial energy evaluation function, (2) several energy minimization algorithms for fine tuning the binding poses, and (3) different scoring functions. This modularity ensures the easy configuration of custom-made protocols that can be optimized depending on the problem in hand. CRDOCK employs a precomputed library of ligand conformations that are initially generated from one-dimensional SMILES strings. Testing CRDOCK on two widely used benchmarks, the ASTEX diverse set and the Directory of Useful Decoys, yielded a success rate of ~75% in pose prediction and an average AUC of 0.66. A typical ligand can be docked, on average, in just ~13 s. Extension to a representative group of pharmacologically relevant G protein-coupled receptors that have been recently cocrystallized with some selective ligands allowed us to demonstrate the utility of this tool and also highlight some current limitations. CRDOCK is now included within VSDMIP, our integrated platform for drug discovery.

Mesh:

Substances:

Year:  2012        PMID: 22764680     DOI: 10.1021/ci300194a

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan.

Authors:  Noemí Bustamante; Manuel Iglesias-Bexiga; Noelia Bernardo-García; Noella Silva-Martín; Guadalupe García; María A Campanero-Rhodes; Esther García; Isabel Usón; Rubén M Buey; Pedro García; Juan A Hermoso; Marta Bruix; Margarita Menéndez
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

2.  Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression.

Authors:  Olaia Martinez-Iglesias; Alba Casas-Pais; Raquel Castosa; Andrea Díaz-Díaz; Daniel Roca-Lema; Ángel Concha; Álvaro Cortés; Federico Gago; Angélica Figueroa
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

3.  Esterase LpEst1 from Lactobacillus plantarum: a novel and atypical member of the αβ hydrolase superfamily of enzymes.

Authors:  Yanaisis Alvarez; María Esteban-Torres; Alvaro Cortés-Cabrera; Federico Gago; Iván Acebrón; Rocío Benavente; Karin Mardo; Blanca de Las Rivas; Rosario Muñoz; José M Mancheño
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.